Edwards Lifesciences 4th-quarter sales, profit top expectations
Feb 1 (Reuters) - Edwards Lifesciences Corp on Wednesday reported higher-than-expected fourth-quarter profit and revenue on surging demand for its minimally invasive heart valve replacement systems. [Source]
Publication Date:Origin: reuters.com
Category: rbssHealthcareNews
Topics: Lifesciences, Edwards, systems, replacement, heart valve, invasive, minimally, demand, surging, revenue, profit and, fourth-quarter, higher-than-expected, reported, on Wednesday, (Reuters), expectations, profit, sales, 4th-quarter
